Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in Antiarrhythmic Drug Therapy
Arnela Saljic, Jordi Heijman, Dobromir Dobrev
Drugs (2023) Vol. 83, Iss. 13, pp. 1147-1160
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Dominik Linz, Jason G. Andrade, Elena Arbelo, et al.
EP Europace (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 33
Novel drug therapies for atrial fibrillation
Felix Wiedmann, Constanze Schmidt
Nature Reviews Cardiology (2024) Vol. 21, Iss. 5, pp. 275-276
Closed Access | Times Cited: 5
Antiarrhythmic Drug Therapy: Where Do We Go From Here?
Peter R. Kowey, Gerald V. Naccarelli
Circulation (2024) Vol. 149, Iss. 11, pp. 801-803
Closed Access | Times Cited: 5
The SK4 channel allosteric blocker, BA6b9, reduces atrial fibrillation substrate in rats with reduced ejection fraction
Shira Burg, Or Levi, Sigal Elyagon, et al.
PNAS Nexus (2024) Vol. 3, Iss. 5
Open Access | Times Cited: 5
Heart–Brain Axis: A Narrative Review of the Interaction between Depression and Arrhythmia
Shuping Fang, Wei Zhang
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1719-1719
Open Access | Times Cited: 5
26‐Week Repeated‐Dose Toxicity Study of a Novel Antiarrhythmic Drug Sulcardine Sulfate in Sprague–Dawley Rats
Liangyu Zhang, Leilei Gu, Hongqun Qiao
Journal of Applied Toxicology (2025)
Closed Access
Stepwise ablation strategy in radiofrequency ablation improves acute and long-term outcomes of scar-related ventricular tachycardias
Pin Wang, Yang-Xian Zuo, Chenglong Miao, et al.
Technology and Health Care (2025)
Closed Access
Transcriptomics, Proteomics and Bioinformatics in Atrial Fibrillation: A Descriptive Review
Martina Belfiori, Ludovico Lazzari, Melanie J. Hezzell, et al.
Bioengineering (2025) Vol. 12, Iss. 2, pp. 149-149
Open Access
Clinical Outcomes of Intracardiac Echocardiography‐Guided Radiofrequency Catheter Ablation for Atrial Fibrillation: A Retrospective Study
Weiying Long, Qingsong He, Shi Chen, et al.
Echocardiography (2025) Vol. 42, Iss. 2
Open Access
A short history of the atrial NLRP3 inflammasome and its distinct role in atrial fibrillation
Theresa Poppenborg, Arnela Saljic, Florian Bruns, et al.
Journal of Molecular and Cellular Cardiology (2025) Vol. 202, pp. 13-23
Open Access
Disease mechanism and novel drug therapies for atrial fibrillation
Constanze Schmidt, Felix Wiedmann
Medizinische Genetik (2025) Vol. 37, Iss. 2, pp. 147-154
Closed Access
Challenges and Opportunities for Atrial Fibrillation Management
Minsi Cai, Jordi Heijman
Cardiology Discovery (2025)
Open Access
Drugs associated with a risk of supraventricular tachycardia: analysis using the OpenVigil database
Weihong Chen, Shaobin Li, Dongqin Huang, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 3
Open Access | Times Cited: 2
Precision individualized medication strategies and challenges for cardiovascular diseases
Ting Yin, Jun Duan, Dong Xu, et al.
Precision medication. (2024) Vol. 1, Iss. 1, pp. 7-15
Open Access | Times Cited: 2
A comparative study of lappaconitine hydrobromide extended release and propafenone in patients with paroxysmal atrial fibrillation
А. Ш. Ревишвили, Golitsyn Sp, S. B. Aksentiev, et al.
Vrach (2024) Vol. 35, Iss. 1, pp. 20-26
Closed Access | Times Cited: 1
Multi-Faceted Potential of Sophoridine Compound's Anti-Arrhythmic and Antioxidant Effects through ROS/CaMKII Pathway
Shuai Sun, Fangdi Shi, Gang Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37542-e37542
Open Access | Times Cited: 1
Promising tools for future drug discovery and development in antiarrhythmic therapy
Gema Mondéjar‐Parreño, Patricia Sánchez-Pérez, Francisco M. Cruz, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100013-100013
Open Access | Times Cited: 1
Functional modelling of arrhythmias with human cardiac organoids
Mark L. Pocock
(2024)
Open Access
New focus on cardiac voltage-gated sodium channel β1 and β1B: Novel targets for treating and understanding arrhythmias?
Zachary J Williams, Laura Beth Payne, Xiaobo Wu, et al.
Heart Rhythm (2024)
Closed Access
Spexin Hormone Signaling and Atrial Fibrillation: The Knowns and Unknowns
Jordi Heijman, Dobromir Dobrev
Circulation (2024) Vol. 150, Iss. 2, pp. 128-131
Closed Access
Arritmia cardíaca: mecanismos, diagnóstico e abordagens terapêuticas
Christovam Abdalla Neto, Juliana Fernandes Areal Carrizo, Amanda da Silva Peixoto, et al.
Caderno Pedagógico (2024) Vol. 21, Iss. 7, pp. e5924-e5924
Closed Access
Recent highlights from the International Journal of Cardiology heart & Vasculature: Comprehensive management of atrial fibrillation
Dominik Linz, Dobromir Dobrev
IJC Heart & Vasculature (2024) Vol. 53, pp. 101478-101478
Open Access
Recent Advances in the Management of Non-rheumatic Atrial Fibrillation: A Comprehensive Review
Abhinav Kadam, Palash S Kotak, Kashish Khurana, et al.
Cureus (2024)
Open Access
Barium Chloride-Induced Cardiac Arrhythmia Mouse Model Exerts an Experimental Arrhythmia for Pharmacological Investigations
Mengting Zeng, Liyue Huang, Xiaohui Zheng, et al.
Life (2024) Vol. 14, Iss. 8, pp. 1047-1047
Open Access
A Comprehensive Review on Stereotactic Arrhythmia Radioablation (STAR): Pioneering a New Era in Arrhythmia Management
Varun N Thawkar, Karuna Taksande
Cureus (2024)
Open Access
Page 1 - Next Page

Scroll to top